KRT20 and colorectal carcinoma: Based on our previous findings on CK20 mRNA expression in liquid biopsies in a small cohort of EC patients and DEFA5 mRNA expression in blood samples of CRC patients, the present study aimed to validate our findings and to investigate whether CK20 and DEFA5 can be used as prognostic markers in liquid biopsies of EC patients.